Member Info for stt1

Good to see the new CFO with his 1st buy.

Chairman buying, CFO buying, IIs adding.

Rivaldo,

Cavendish are the company NOMAD and joint broker. It is their job to promote the company.

The link to the rns

Why then did the sitting chairman need to dump his entire holding and just 4 working days after the TU?

https://polaris.brighterir.com/public/hvivo/news/rns/story/xpdodqx/export

I consider that a huge red flag.

Hallsworthy will be happy to see the new CFO of TLY has bought today, the chairman was buying and IIs have been adding.

There you go, the chairman timed his sell well.

He dumped his entire holding just 4 working days after the TU/investor presentation.

As I've said, I believe he knows the company better than any II or PI.

The results show lack of growth and obviously the chairman knew that when he dumped his entire holding.

Any drop of revenue or order book will not look good.

They need to keep revenues and order book growing.

What would happen if revenues fall?.

In terms of the other companies I mention, obviously some will not want the gullible to work out the truth for themselves!!!

Do some research into Byot.

And Nexn, was called trmr, was rthm, was blnx - going back to 2007.

They all crashed due to red flags I warned about. Byot 99.9%, blnx 90%, rthm/trmr 80%.

Look at Nano, recently crashed 80% due to red flags I warned about.

I don't think it's a coincidence that the same rampers were ramping those and are now HVO. It's easy for admin to check the multiple ids.

Apart from CEO's credibility.

The sitting Chairman dumped his entire holding in 2 tranches. Both tranches, the company was being talked up when he dumped majority of his holding in Feb and then the remaining just 4 working days after the TU/investor presentation.

The sitting chairman knows the company better than any II.

Anyone care to counter the opinion that the sitting chairman dumping his entire holding within 4 working days of the TU/investor presentation is not a huge red flag???

My other rational bear points:

I believe there is a questionable business model.

There is lack of significant growth rate in revenues/order book.

The newsflow here has been as expected:

Govn to issue report on state of NHS and their plans.

It is this report/plans which will determine the direction of the NHS and not what happened in the past.

TLY is aligned to the NHS and so have to adapt to NHS requirements, which is what they have been doing. Hence the acquisitions.

Streeting sets out three NHS ‘shifts’ ahead of Darzi review publication

https://www.pulsetoday.co.uk/news/politics/streeting-sets-out-three-nhs-shifts-ahead-of-darzi-review-publication/

No contracts announced since TU then???

I expect the company will be talked up, more talk about the new facility!!!

Let's see what forecast they give for fy2025 and whether they make any comments on the chairman dumping his entire holding 4 days after the TU.

GP Collective Action.

Some GPs are restricting number of appointments to 25 per day.

This will lead to more patients turning to other services like NHS 111, Urgent Care Centres etc

https://www.theguardian.com/society/article/2024/aug/13/nearly-half-of-englands-gp-surgeries-taking-industrial-action-survey-finds

Having won the £10m resilience contract, TLY is the Core Provider of resilience services to NHS England's NHS 111 service.

"Totally has significant experience in providing quality, resilient and responsive NHS 111 services. To date we have answered almost half a million calls as part of the NHS England's National Resilience programme. These calls would otherwise have gone unanswered leaving those seeking to access care without the support they needed. As demand has increased, we have responded, increasing capacity to ensure that calls to NHS 111 across the country are not abandoned.

The extension of this contract for a further year means that Totally continues to be a core partner in the delivery of NHS 111 services until February 2025."

https://www.totallygroup.com/news-and-media/news/totally-provide-national-contingency-support-nhs-111-further-year/

Thompi

"CF is an entrepreneur. He clearly likes new projects and challenges - he has a new company and financial interests".

First and foremost, he is the sitting chairman. A sitting chairman's responsibility is to the shareholders and not his own pocket.

Simple point. I believe the chairman knows more about the company than any II or PI, don't you agree?

"He hasn’t just ‘irresponsibly’ dumped his stake in HVO"

Yes, he has. He dumped the majority of his holding in Feb soon after the company was talked up. He dumped the remaining holding as soon as he could, 4 working days after the TU/investor presentation.

"he has ‘transferred’ it to Octopus Investments"

No he hasn't. Octopus own 8%, don't they? Little bit more than the chairman dumped. The large trades proves that it was possible to buy quantities in the market. If the chairman transferred his holding to Octopus, as you claim then how come other IIs also got some???

" who have built up a significant shareholding."

The CEO > 7m options, which is also a significant number of options to award to one snr exec. It gives him the incentive to talk up the company until the options are exercisable. Those options awarded only last year and crucially back dated by a year!!

" I much prefer Mo’s qualities now at the helm."

The usual rampers always say the same... whoever in charge was better than the previous as it pulls the wool over the gullible readers.

The fact is CF is still the sitting chairman and still pulling the strings.

He doesn't need a normal divi as he's taken his entire holding off the table.

I believe the chairman knows more about the company than any II or PI.

Geordie,

"Wasn't H1 up 30% on H1 last year. Yeah, bloody awful growth that"

Why isn't fy growing by 30% then?

Look at the company's own figures, H1 has shown significant growth, yet fy growth rate has slowed significantly, as well as the order book.

H1 2022

H1 revenue: £18.9m

Order: £70m

fy 2022

rev: £50.7m

Order book: £76m

H1 2023

Revenue: £27.3m (+52%)

Order: £78m

fy 2023

rev: £56m (+10.4%)

Order: £80m

fy 2024

Expected Rev £62m (up 10.7%)

H1 2024

Revenue: £35.6m (+30.6%)

Order book: £71m

fy 2025 est

67.4m (+8.7%)

Therefore,

H1 2023 +52%, YET fy2023 was up 10.3%

H1 2024 +30% (H1 2023 +52%), YET fy estimate is up only 10%

As you claim to understand accounts etc, where the fy growth of 30%?

" you have zero understanding of finance and absolutely zero credibility of any of these chat boards. "

Why not ignore me, load up, sit back, enjoy those returns you're expecting to roll in? You won't because you know the concerns/red flags are there.

Sparkington

"Constantly focusing on revenue is missing the big story here which is EBITDA growth. "

The company, themselves focus on the £100m revenue target.

In fact, my reply was to your mention of the revenue target.

If the upside was so great then the sitting chairman, a renowned businessman wouldn't have dumped his entire holding in 2 tranches. He could have sold down a few and waited - as can be seen over the past 3 weeks there have been no announcements which would have stopped him from selling. But no, 4 working days within the TU/investor presentation and dumped.

The large trades since then proves large number of shares can be traded in

market.

What does the chairman know?

Thinice

"not least because his investments are usually quite high risk. "

That's exactly my point, HVO is high risk. Lack of revenue growth rate.

Investor presentation then within 4 working days, sitting chairman dumps his entire holding.

NHS waiting lists continue to increase.

7.62m on NHS England waiting lists.

Figures pre-GE

NHS waiting lists surge for third month in a row, new figures reveal

"about 7.62 million treatments were awaiting completion at the end of June for 6.39 million patients in England, a slight increase from 7.60 million treatments and 6.37 million patients in May.

The number of people waiting over 65 weeks for treatment increased slightly to 58,024 in June, up from 55,955 the previous month.

Meanwhile, those waiting more than 52 weeks decreased to 302,693, down from 307,500."

https://www.itv.com/news/2024-08-08/nhs-waiting-lists-surge-for-third-month-in-a-row-new-figures-reveal

Sparking

"He never intended to hold OPRH now HVO for ever and I don't think he intended to hold for as long as he did."

You miss the point. He's the sitting chairman. If he intended to be an investor and not chairman then he should have resigned ages ago. Whereas he has continued to pull the strings.

The lack of comment from the company re the Chairman dumping his entire holding says a lot.

"They have laid out a target of £100m revenue here which is not hard to achieve in the time scale."

The £100m revenue target is for year's ahead. It'll keep investors talking about it until nearer the time. It means nothing if their only target £100m over 5 years, which is only relatively small revenue growth from £62m for this year.

Where's the huge revenue growth then?

BigDogg,

Congratulations on making a profit.

It's not just the chairman dumping his entire holding which is the red flag. Worse is the timing, have a look at when he sold his 2 tranches. Whilst the company is being talked up. The CEO, just happens to have huge >7m options, awarded only last year and exercisable from a few months time.

That, together with the sitting chairman selling makes them a huge red flag.

HVO rampers going onto TLY thread to deramp an illiquid share, which moves on small trades, is also a red flag. Although it presents me with an opportunity to top up there.

I think the business model here is questionable.

Hotchip,

I disagree.

I think it's crucial to look at both who's buying and selling.

In this case the sitting chairman has sold his entire holding, which carries more wait than any buying by IIs or PI holding.

I believe the chairman knows the company better than any II or PI?

Only a few months ago, the sitting Chairman's holding wasn't far off Octopus' new holding.

Yet he dumped his entire holding in 2 tranches, the latest just 4 working days after the TU/investor presentation.

What does the sitting chairman know? He obviously knows the company better than any II or PI.

Hallsworthy,

That's true, IIs adding whilst all the noise. You'd be happy TLY IIs were adding as well!

I wonder who was selling here though with those 1m sells. It can't be the sitting chairman as he's already dumped all his holding.

Who do you think is the seller?

II's use client money, so not as powerful a message as snr execs selling.